tiprankstipranks
Trending News
More News >
Piramal Pharma Limited (IN:PPLPHARMA)
:PPLPHARMA
India Market
Advertisement

Piramal Pharma Limited (PPLPHARMA) Financial Statements

Compare
6 Followers

Piramal Pharma Limited Financial Overview

Piramal Pharma Limited's market cap is currently ₹263.86B. The company's EPS TTM is ₹-0.8; its P/E ratio is 268.35; and it has a dividend yield of 0.07%. Piramal Pharma Limited is scheduled to report earnings on July 28, 2025, and the estimated EPS forecast is ₹-0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Currency in INR

Piramal Pharma Limited Earnings and Revenue History

Piramal Pharma Limited Debt to Assets

Piramal Pharma Limited Cash Flow

Piramal Pharma Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis